Trials / Completed
CompletedNCT06084156
A Study to Evaluate the DDI of HSK7653 With Metformin
A Phase I Clinical Study to Evaluate the Drug-Drug Interaction Between HSK7653 and Metformin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a Phase 1, single center, open-label, single arm, drug-drug interaction study of HSK7653 and metformin in Healthy Subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK7653 | Part 1: Day 1 to Day 4, not take; Part 2: Day 6 - Take HSK7653 35 mg; HSK7653 25 mg on day 13, day 20, day 27, and day 34; Part 3: Day 41 - Take HSK7653 25 mg |
| DRUG | Metformin | Part 1: Day 1 to Day 4, 1000mg BID; Part 2: Not take; Part 3: Day 38- day 47, 1000mg BID |
Timeline
- Start date
- 2019-08-10
- Primary completion
- 2019-12-09
- Completion
- 2019-12-09
- First posted
- 2023-10-16
- Last updated
- 2023-10-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06084156. Inclusion in this directory is not an endorsement.